Herceptin targets which receptor?

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

Herceptin targets which receptor?

Explanation:
Herceptin targets the HER2 receptor. HER2 is a receptor tyrosine kinase that, when overexpressed, drives breast cancer growth. Trastuzumab binds to the extracellular part of HER2, blocking signaling by preventing receptor dimerization and promoting receptor downregulation. This reduces activity in pathways like PI3K/AKT and MAPK, slowing tumor cell growth and promoting immune-mediated destruction via antibody-dependent cellular cytotoxicity. The other markers listed are not the drug’s target: estrogen receptor and progesterone receptor indicate hormone-driven cancers and guide endocrine therapy, while GATA3 is a transcription factor, not a membrane receptor. Therefore, HER2 is the correct target.

Herceptin targets the HER2 receptor. HER2 is a receptor tyrosine kinase that, when overexpressed, drives breast cancer growth. Trastuzumab binds to the extracellular part of HER2, blocking signaling by preventing receptor dimerization and promoting receptor downregulation. This reduces activity in pathways like PI3K/AKT and MAPK, slowing tumor cell growth and promoting immune-mediated destruction via antibody-dependent cellular cytotoxicity. The other markers listed are not the drug’s target: estrogen receptor and progesterone receptor indicate hormone-driven cancers and guide endocrine therapy, while GATA3 is a transcription factor, not a membrane receptor. Therefore, HER2 is the correct target.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy